Literature DB >> 6311862

Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women.

J H Liu, K Muse, P Contreras, D Gibbs, W Vale, J Rivier, S S Yen.   

Abstract

In order to study the interaction between vasopressin (VP) and hypothalamic corticotropin releasing factor (CRF) on the release of ACTH, VP and CRF were administered separately and in combination to normal cycling women. The combined hormones raised plasma ACTH levels higher than the sum of the separate responses and 5 times more than CRF alone. This study reveals for the first time synergism between VP and CRF in their ACTH releasing effects in humans.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6311862     DOI： 10.1210/jcem-57-5-1087

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Stress-related reproductive failure.

Authors:  E R Barnea; J Tal
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-02

2.  Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.

Authors:  Tracy L Bale; Roberto Picetti; Angelo Contarino; George F Koob; Wylie W Vale; Kuo-Fen Lee
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  Corticotropin releasing factor (CRF): diagnostic implications.

Authors:  O A Müller; G K Stalla; J Hartwimmer; J Schopohl; K von Werder
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

4.  Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.

Authors:  K T Kalogeras; L K Nieman; T C Friedman; J L Doppman; G B Cutler; G P Chrousos; R L Wilder; P W Gold; J A Yanovski
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

5.  A comparison of pituitary-adrenal responses to corticotropin-releasing hormone, hypoglycaemia and metyrapone in children with brain tumours and growth hormone deficiency.

Authors:  I Fujiwara; Y Igarashi; E Ogawa
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

6.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

7.  Corticotropin- and growth hormone-releasing factor (CRF and GRF) in the diagnosis of hypothalamo-pituitary diseases.

Authors:  K von Werder; O A Müller
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.